Promising new cancer-fighting drugs are the big topic at a conference in Chicago this week.
The drugs are proving effective against prostate, lung and breast cancers, beyond the first year of treatment.
Studies suggest the drug Zytiga will become a first-treatment choice for men whose prostate cancer has spread.
For advanced lung cancer with a certain gene flaw, the drug Alecensa stopped cancer growth for 15 months longer than current medication and a relatively new drug called Lynparza showed promise.
For women with a gene that raises their risk for breast cancer.
Segment Sponsored By: Mercy Health Systems